BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 18446711)

  • 1. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure.
    Cottone S; Lorito MC; Riccobene R; Nardi E; Mulè G; Buscemi S; Geraci C; Guarneri M; Arsena R; Cerasola G
    J Nephrol; 2008; 21(2):175-9. PubMed ID: 18446711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inflammation, oxidative stress and kidney function in arterial hypertension].
    Cerasola G; Guarneri M; Cottone S
    G Ital Nefrol; 2009; 26 Suppl 46():8-13. PubMed ID: 19644813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin-1 and F2-isoprostane relate to and predict renal dysfunction in hypertensive patients.
    Cottone S; Mulè G; Guarneri M; Palermo A; Lorito MC; Riccobene R; Arsena R; Vaccaro F; Vadalà A; Nardi E; Cusimano P; Cerasola G
    Nephrol Dial Transplant; 2009 Feb; 24(2):497-503. PubMed ID: 18772174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiovascular system in patients in different stages of chronic kidney disease].
    Strózecki P; Kozłowski M; Grajewska M; Kurowski R; Stefańska A; Odrowaź-Sypniewska G; Serafin Z; Lasek W; Nartowicz E; Kubica J; Manitius J
    Pol Merkur Lekarski; 2006 Aug; 21(122):125-9; discussion 130-1. PubMed ID: 17144094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effect of simvastatin on inflammation and oxidative stress in chronic kidney disease.
    Dummer CD; Thome' FS; Zingano B; Lindoso A; Veronese FV
    J Nephrol; 2008; 21(6):900-8. PubMed ID: 19034875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction and chronic kidney disease: treatment options.
    Wu-Wong JR
    Curr Opin Investig Drugs; 2008 Sep; 9(9):970-82. PubMed ID: 18729004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease.
    Roberts MA; Hare DL; Ratnaike S; Ierino FL
    Am J Kidney Dis; 2006 Sep; 48(3):341-60. PubMed ID: 16931208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular senescence, cardiovascular risk, and CKD: a review of established and hypothetical interconnections.
    Tsirpanlis G
    Am J Kidney Dis; 2008 Jan; 51(1):131-44. PubMed ID: 18155543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linking oxidative stress and inflammation in kidney disease: which is the chicken and which is the egg?
    Himmelfarb J
    Semin Dial; 2004; 17(6):449-54. PubMed ID: 15660575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease.
    Kendrick J; Chonchol MB
    Nat Clin Pract Nephrol; 2008 Dec; 4(12):672-81. PubMed ID: 18825155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy.
    Himmelfarb J
    Semin Dial; 2009; 22(6):636-43. PubMed ID: 20017834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular disease and chronic renal failure: new insights.
    Nanayakkara PW; Gaillard CA
    Neth J Med; 2010 Jan; 68(1):5-14. PubMed ID: 20103816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of aerobic exercise and resistance training in patients with and without chronic kidney disease.
    Moinuddin I; Leehey DJ
    Adv Chronic Kidney Dis; 2008 Jan; 15(1):83-96. PubMed ID: 18155113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What we know about oxidative stress in patients with chronic kidney disease on dialysis--clinical effects, potential treatment, and prevention.
    Del Vecchio L; Locatelli F; Carini M
    Semin Dial; 2011; 24(1):56-64. PubMed ID: 21299632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of chronic kidney disease on postinfarction inflammation, oxidative stress, and left ventricular remodeling.
    Naito K; Anzai T; Yoshikawa T; Anzai A; Kaneko H; Kohno T; Takahashi T; Kawamura A; Ogawa S
    J Card Fail; 2008 Dec; 14(10):831-8. PubMed ID: 19041046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial function, CRP and oxidative stress in chronic kidney disease.
    Annuk M; Soveri I; Zilmer M; Lind L; Hulthe J; Fellström B
    J Nephrol; 2005; 18(6):721-6. PubMed ID: 16358230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are biomarkers useful for assessing cardiovascular risk in patients with chronic kidney disease?
    Rubin C; Nolin TD; Himmelfarb J
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):506-11. PubMed ID: 18089962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic kidney disease (CKD) as an independent risk factor for cardiovascular disease (CVD)].
    Minami J; Ishimitsu T; Sudo Y; Matsuoka H
    Nihon Rinsho; 2008 Sep; 66(9):1657-63. PubMed ID: 18788391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causes and consequences of increased arterial stiffness in chronic kidney disease patients.
    Gusbeth-Tatomir P; Covic A
    Kidney Blood Press Res; 2007; 30(2):97-107. PubMed ID: 17374960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.